Pseudo-Richter transformation of chronic lymphocytic leukaemia/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall
Open Access
- 1 October 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 191 (1), E22-E25
- https://doi.org/10.1111/bjh.16948
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformationCancer, 2018
- Chronic lymphocytic leukemia treatment algorithm 2018Blood Cancer Journal, 2018
- Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive reviewHaematologica, 2018
- Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemiaHaematologica, 2018
- Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLLBlood, 2017
- Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLLBlood Advances, 2017
- How I manage ibrutinib-refractory chronic lymphocytic leukemiaPublished by American Society of Hematology ,2017
- Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic LeukemiaJAMA Oncology, 2015
- Risk Factors for Richter Syndrome in Chronic Lymphocytic LeukemiaCurrent Hematologic Malignancy Reports, 2014
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2013